Plasma exchange for severe alveolar hemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: emulation of a target trial.
Sanna AC, Gendreau S, Desnos C, Lombardi R, Malherbe J, Titeca-Beauport D, Reizine F, Louis G, Nassarmadji K, Campagne J, Martellosio JP, Deroux A, Bendiab E, Coirier V, Catano J, Pineton De Chambrun M, Samson M, Vigneron C, Néel A, Smets P, Deltombe T, Brilland B, Desgrouas M, Simon O, Faguer S, Giorgiutti S, Paule R, Arrive F, Masson I, Quéméneur T, Durel CA, de Montmollin E, Quenot JP, Perrin F, Lobbes H, Lajoye Q, Mesbah R, Outh R, Thoreau B, Lacraz A, Philipponnet C, Contou D, Parazols F, Garo F, Blonz G, Ducoux G, Yildiz H, Rey I, Di Ascia L, Issa N, Le Guen P, Queyrel V, Eid R, Arcani R, Uzunhan Y, Puéchal X, Porcher R, de Prost N, Terrier B; French Vasculitis Study Group (FVSG) and the Groupe de Recherche en Réanimation Respiratoire du patient d‘Onco-Hématologie (GrrrOH).
Sanna AC, et al.
Am J Respir Crit Care Med. 2026 Apr 1;212(4):757-767. doi: 10.1093/ajrccm/aamaf122.
Am J Respir Crit Care Med. 2026.
PMID: 41738152
Baseline characteristics were similar, except for more severe renal impairment (creatinine 357 vs 171 mol/L, P = .01) and more frequent cyclophosphamide use (77% vs 55%, P = .01) in the PLEX group. ...
Baseline characteristics were similar, except for more severe renal impairment (creatinine 357 vs 171 mol/L, P = .01) and more frequ …